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LETTERS
Babesia venatorum 
Infection in Child, 
China
To the Editor: Babesiosis, 
which is caused by intraerythrocytic 
sporozoites of the genus Babesia, 
is a tick-borne emerging zoonosis 
in humans. Although >100 Babesia 
species infect animals, only a few 
species, mainly B. microti and B. 
divergens, infect humans. Human 
infections with B. microti have been 
reported from the United States and 
other countries, and most human in-
fections with B. divergens have been 
reported from Europe (1). Another 
species, B. venatorum, was found to 
infect humans in some countries in 
Europe (2,3).
Only 12 babesiosis case-patients 
have been reported in China, 10 of 
whom were infected with B. microti 
(4–6) and 2 with B. divergens (7). We 
report a case of babesiosis caused by 
B. venatorum in a child and character-
ize the isolated pathogen.
On April 16, 2012, an 8-year-
old boy who lived in Pishan County, 
Xinjiang Autonomous Region, China, 
was admitted to Friendship Hospital in 
Beijing because of an irregular fever 
(38.6°C–41.0°C) for 12 days, anemia, 
malaise, myalgia, fatigue, progressive 
weakness, and shortness of breath. 
Before admission, he was given oral 
cefixime (80 mg/day for 5 days) at a 
local clinic, but no clinical improve-
ment was observed.
At admission, the patient had a 
body temperature of 38.7°C, a pulse 
rate of 76 beats/min, a blood pres-
sure of 110/70 mm Hg, and a respira-
tion rate of 18 breaths/min. Labora-
tory tests identified hemoytic anemia 
(erythrocyte count 2.7 × 109 cells/L, 
hemoglobin level 8.6 g/dL), throm-
bocytopenia (147 × 109 platelets/L), 
increased levels of serum lactate de-
hydrogenase (1,462 U/L) and bili-
rubin (2.6 mg/dL), and an increased 
leukocyte count (17 × 109 cells/L with 
72% neutrophils, 24% lymphocytes, 
1% monocytes, 2% eosinophils, and 
1% basophils). Levels of C-reactive 
protein (14.2 mg/dL) and procalcito-
nin (3.1 mg/dL) were increased, which 
suggested an inflammatory process.
Forty-eight hours after the pa-
tient’s admission, a thin peripheral 
blood smear stained with Giemsa was 
prepared. A presumptive diagnosis of 
babesiosis was made on the basis of 
microscopic observation of intraeryth-
rocytic parasites (parasitemia level 
≈5%) with typical ring-like tropho-
zoites, paired pyriforms, and tetrads 
(Figure, panel A).
DNA was extracted from a pa-
tient blood sample. PCR specific for a 
partial 18S rRNA gene sequence was 
performed with primers PIRO-A and 
PIRO-B (8) and showed a positive re-
sult for a Babesia sp. The patient was 
then treated with azithromycin (12 
mg/kg once a day for 7 days) and ato-
vaquone (20 mg/kg twice a day for 7 
days). His clinical manifestations im-
proved 3 days after treatment, although 
parasites were still detectable in blood 
smears. On May 17, negative results 
for blood smears and PCR indicated 
that the parasite had been cleared. The 
boy was discharged on May 20, 2012, 
and has remained healthy.
A 0.5-mL blood sample obtained 
from the patient before treatment was 
injected intraperitoneally into 3 se-
verely combined immunodeficient 
mice. Mice were monitored for para-
sitemia every 3 days. When tested 6–9 
days postinjection, all 3 mice were 
positive for a Babesia sp. (Figure, 
panel B). We tested for IgG against 
B. venatorum and B. microti by using 
an indirect immunofluorescence assay 
(9). Seroconversion against B. venato-
rum was evident; reciprocal antibody 
titers of 16 in an acute-phase sample 
(admission) and 128 in a convales-
cent-phase (discharge) sample. Re-
sults for B. microti were negative.
Nucleotide sequences of PCR 
products from patient and mice blood 
samples were identical to the corre-
sponding sequence of B. venatorum 
18S rRNA. The complete 18S rRNA 
gene of the Babesia parasite isolated 
from the patient was amplified with 
primers CRYPTOF and CRYPTOR 
(2). This PCR product was se-
quenced, and the sequence was sub-
mitted to GenBank under accession 
no. KF724377.
B. venatorum was first known as 
Babesia sp. EU1 and was named after 
the Latin word for hunter because the 
first reported infected patients were 
2 occupational hunters from Austria 
and Italy (2). One human infection 
with B. venatorum was also reported 
from Germany (3). All 3 case-patients 
were men >50 years of age who had 
undergone splenectomies for severe 
Hodgkin disease before Babesia 
sp. infection.
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Figure.	A)	Giemsa-stained	 thin	 blood	 smear	 for	 an	 8-year-old	 boy	 from	China	 showing	
erythrocytes	 with	 typical	 ring	 forms,	 paired	 pyriforms,	 and	 tetrads	 of	 a	 Babesia	 sp.	




Previously reported babesiosis 
cases in children have been mostly 
acquired by blood transfusion (10). 
The patient had no history of trans-
fusions with blood products and had 
never traveled outside his home town 
before disease onset. Although he 
and his parents did not recall any tick 
bites, he was at high risk for expo-
sure to ticks because he often played 
with his dog, which frequently went 
outdoors in a tick-infested forested 
area. The dog may have transmitted a 
Babesia sp.–infected tick to the pa-
tient. However, ticks from the dog 
were not available for identification 
and testing.
The patient in our study was pre-
sumed to be healthy and immunocom-
petent, which indicates that Babesia 
species can cause infections even in 
healthy persons. Babesiosis should be 
considered in the differential diagno-
sis of patients with a history of tick 
exposure and prolonged and irregu-
lar fever. Blood smear evaluation for 
intraerythrocytic parasites should be 
considered.
The patient was treated with 
azithromycin and atovaquone and the 
parasites were cleared within 1 month. 
This combined treatment was well 
tolerated and effective, and it can be 
recommended as an alternative treat-
ment to the commonly used therapy of 
quinine and clindamycin (1).
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and Klebsiella  
pneumoniae in 
Gulls, Alaska, USA
To the Editor: Resistance to 
β-lactam antibacterial drugs has spread 
rapidly, particularly through the CTX-
M β-lactamase enzymes (CTX-M) (1). 
Although CTX-Ms are geographically 
widely distributed, reports of extended-
spectrum β-lactamase (ESBL) dissem-
ination are few from remote regions. 
In 2008, we reported phenotypic resis-
tance traits in Escherichia coli isolates 
in 8.2% of wild birds sampled in the 
Arctic (2). We sampled approximately 
260 wild birds, mainly gulls and geese, 
but found no ESBL-harboring isolates 
(J. Bonnedahl et al., unpub. data). Here 
we report results of our 2010 study at 
Barrow, Alaska, USA, a follow up to 
our 2005 study in which we found van-
comycin-resistant enterococci (VRE) 
with clear traits of human origin in 
glaucous gulls (3). Our findings show 
a remarkable change, not in VRE dis-
semination, which is fairly unchanged, 
but in the emergence of ESBLs and 
general resistance of E. coli isolates.
We collected 150 fecal samples 
from a population of adult gulls resid-
ing close to a landfill site. For a de-
scription of general resistance levels 
(4,5), susceptibility of 1 randomly se-
lected E. coli isolate per sample (137 
isolated from 150 samples) was test-
ed to a set of 10 antibacterial agents. 
Nearly half (48%) of the 137 E. coli 
isolates were resistant to at least 1 of 
the drugs tested. Resistance to 1 or 
2 antimicrobial agents was found in 
32% and 13% of the tested isolates, 
respectively, and resistance to >3 
was found in 3% of isolates (online 
Technical Appendix Table, wwwnc.
cdc.gov/EID/article/20/5/13-0325-
Techapp1.pdf).
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